Table 1

Demographic characteristics and primary outcome measure, the number of active lesions/scan (Mean [SEM])
Patient
 Age
 Sex
 EDSS
 Duration of disease
 Mean number of active lesions per monthly scan
 Change, mean lesion number


F/M
years
 baseline period
 treatment period
 %
All patients
 32.7 [1.4]
 8/1
 1.5 [0.33]
 6.3 [2.0]
 3.55 [0.78]
 2.15 [0.69]
 - 39.4
p = 0.013*
01
 25
 F
 0
 1
 1
 0,5
 - 50
02
 32
 F
 0
 2.5
 1.83
 0
 - 100
03
 31
 F
 2.0
 5
 7.67
 5.83
 - 34
04
 34
 F
 1.5
 4
 2.33
 2.83
 + 21
05
 34
 F
 1.0
 0.3
 6
 3.67
 - 38
06
 36
 M
 2.5
 11.3
 4.5
 0.67
 - 85
07
 40
 F
 2.5
 15
 1
 0.17
 - 83
08
 33
 F
 2.5
 15
 4.83
 4.17
 - 14
09
 30
 F
 1.5
 3
 2.67
 1.5
 - 38





Median change
 - 43.8 %





Mean change
 - 46.4 %

* p for testing baseline vs. treatment period (Wilcoxon Matched-Pairs Signed-Ranks test for related samples).

Then Bergh et al. BMC Neurology 2006 6:19   doi:10.1186/1471-2377-6-19